Literature DB >> 25805574

CD1d-dependent endogenous and exogenous lipid antigen presentation.

Rosanna M McEwen-Smith1, Mariolina Salio1, Vincenzo Cerundolo2.   

Abstract

Invariant natural killer T (iNKT) cells recognize endogenous and exogenous lipids in the context of CD1d molecules, and through the activation and maturation of dendritic cells and B cells, can significantly enhance priming of antigen-specific T and B cell responses. Recent findings have provided important insights into the recognition of several novel endogenous lipids by iNKT cells, and into the mechanisms controlling their generation and loading onto CD1d molecules. In this review we discuss these latest findings and describe the role of autophagy in iNKT cell development and activation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25805574     DOI: 10.1016/j.coi.2015.03.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  18 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

Review 2.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

Review 3.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

Review 4.  Mechanisms and Consequences of Antigen Presentation by CD1.

Authors:  Luc Van Kaer; Lan Wu; Sebastian Joyce
Journal:  Trends Immunol       Date:  2016-09-09       Impact factor: 16.687

Review 5.  Endogenous lipid antigens for invariant natural killer T cells hold the reins in adipose tissue homeostasis.

Authors:  Robert J van Eijkeren; Olga Krabbe; Marianne Boes; Henk S Schipper; Eric Kalkhoven
Journal:  Immunology       Date:  2017-10-26       Impact factor: 7.397

6.  Two bacterial glycosphingolipid synthases responsible for the synthesis of glucuronosylceramide and α-galactosylceramide.

Authors:  Nozomu Okino; Mengbai Li; Qingjun Qu; Tomoko Nakagawa; Yasuhiro Hayashi; Mitsufumi Matsumoto; Yohei Ishibashi; Makoto Ito
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

Review 7.  Early innate responses to pathogens: pattern recognition by unconventional human T-cells.

Authors:  Anna Rita Liuzzi; James E McLaren; David A Price; Matthias Eberl
Journal:  Curr Opin Immunol       Date:  2015-07-13       Impact factor: 7.486

8.  The lysophospholipid-binding molecule CD1D is not required for the alloimmunization response to fresh or stored RBCs in mice despite RBC storage driving alterations in lysophospholipids.

Authors:  Jelena Medved; Brittney M Knott; Soraya N Tarrah; Andria N Li; Neha Shah; Tamara C Moscovich; Alexis R Boscia; Juan E Salazar; Manjula Santhanakrishnan; Jeanne E Hendrickson; Xiaoyun Fu; James C Zimring; Chance John Luckey
Journal:  Transfusion       Date:  2021-06-28       Impact factor: 3.337

9.  Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling.

Authors:  Anna Rita Liuzzi; Ann Kift-Morgan; Melisa Lopez-Anton; Ida M Friberg; Jingjing Zhang; Amy C Brook; Gareth W Roberts; Kieron L Donovan; Chantal S Colmont; Mark A Toleman; Timothy Bowen; David W Johnson; Nicholas Topley; Bernhard Moser; Donald J Fraser; Matthias Eberl
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

Review 10.  Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials.

Authors:  Mariolina Salio; Vincenzo Cerundolo
Journal:  Front Immunol       Date:  2015-07-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.